• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[老年患者经皮腔内冠状动脉成形术后再狭窄——危险因素分析]

[Restenosis after percutaneous transluminal coronary angioplasty in the elderly--risk factor analysis].

作者信息

Ishikawa Y, Fujioka Y, Kitagawa Y, Nobusawa A, Takahashi A, Taniguchi T, Yokoyama M

机构信息

First Department of Internal Medicine, Kobe University School of Medicine.

出版信息

Nihon Ronen Igakkai Zasshi. 1995 Jul;32(7):491-6. doi: 10.3143/geriatrics.32.491.

DOI:10.3143/geriatrics.32.491
PMID:7500552
Abstract

Utilization of percutaneous transluminal coronary angioplasty (PTCA) has dramatically expanded even in the management of elderly patients with coronary artery disease. However, restenosis after successful PTCA remains the major problem limiting the long-term efficacy of the procedure. Reported restenosis rates vary from 25 to 43%. In order to determine the relationship of restenosis to coronary risk factors in the elderly, we analyzed the data in 87 patients who had undergone PTCA and angiography before and 3 to 6 months after PTCA. Of these, 29 patients were 65 years of age or older (elderly group) and 58 were less than 65 years of age (younger group). Restenosis, defined as a luminal narrowing of greater than 50% at follow-up time, was found in 20 of the elderly group (69.0%), and in 26 (44.8%) of younger group (p < 0.0001). Total cholesterol, LDL cholesterol, apolipoprotein B (apo B), and the ratio of apoB/apoA1 in the elderly group were significantly lower than those in the younger group. HDL cholesterol levels were lower than 40 mg/dl in both groups (not significant). Each group was subdivided into two types; restenosis type and non-restenosis type. There were no significant differences in serum lipid, apolipoprotein, and lipoprotein(a) levels between the 2 subtypes in each group. The degree of coronary atherosclerosis calculated by Gensini's method, the number of damaged coronary vessels, diabetes mellitus, hypertension, and smoking did not appear to affect the rate of restenosis in either group.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

即使在老年冠心病患者的治疗中,经皮腔内冠状动脉成形术(PTCA)的应用也已大幅扩展。然而,PTCA成功后的再狭窄仍是限制该手术长期疗效的主要问题。报道的再狭窄率在25%至43%之间。为了确定老年患者再狭窄与冠状动脉危险因素之间的关系,我们分析了87例在PTCA术前及术后3至6个月接受PTCA和血管造影患者的数据。其中,29例患者年龄在65岁及以上(老年组),58例患者年龄小于65岁(年轻组)。再狭窄定义为随访时管腔狭窄大于50%,老年组中有20例(69.0%)出现再狭窄,年轻组中有26例(44.8%)出现再狭窄(p<0.0001)。老年组的总胆固醇、低密度脂蛋白胆固醇、载脂蛋白B(apo B)以及apoB/apoA1比值均显著低于年轻组。两组的高密度脂蛋白胆固醇水平均低于40mg/dl(无显著差异)。每组又分为两种类型:再狭窄型和非再狭窄型。每组的两个亚组之间在血脂、载脂蛋白和脂蛋白(a)水平上无显著差异。用Gensini法计算的冠状动脉粥样硬化程度、受损冠状动脉血管数量、糖尿病、高血压和吸烟似乎对两组的再狭窄率均无影响。(摘要截断于250字)

相似文献

1
[Restenosis after percutaneous transluminal coronary angioplasty in the elderly--risk factor analysis].[老年患者经皮腔内冠状动脉成形术后再狭窄——危险因素分析]
Nihon Ronen Igakkai Zasshi. 1995 Jul;32(7):491-6. doi: 10.3143/geriatrics.32.491.
2
Restenosis after transluminal coronary angioplasty: a risk factor analysis.
J Cardiovasc Risk. 1995 Feb;2(1):51-5.
3
Association of an acute reduction in lipoprotein(a) with coronary artery restenosis after percutaneous transluminal coronary angioplasty.经皮腔内冠状动脉成形术后脂蛋白(a)急性降低与冠状动脉再狭窄的关联。
Circulation. 1997 Jul 1;96(1):166-73.
4
Usefulness of serum lipoprotein (a) as a predictor of restenosis after percutaneous transluminal coronary angioplasty.血清脂蛋白(a)作为经皮腔内冠状动脉成形术后再狭窄预测指标的实用性。
Am J Cardiol. 1992 Mar 15;69(8):736-9. doi: 10.1016/0002-9149(92)90497-m.
5
The relationship between serum lipoprotein(a) and restenosis after initial elective percutaneous transluminal coronary angioplasty.初次择期经皮腔内冠状动脉成形术后血清脂蛋白(a)与再狭窄的关系。
Jpn Circ J. 1993 Aug;57(8):789-95. doi: 10.1253/jcj.57.789.
6
Short-term and long-term effects of low-density lipoprotein (LDL) apheresis on restenosis after percutaneous transluminal coronary angioplasty (PTCA): is lowering Lp(a) by LDL apheresis effective on restenosis after PTCA?
Ther Apher. 1998 Feb;2(1):65-70. doi: 10.1111/j.1744-9987.1998.tb00075.x.
7
Fibrinogen values in patients with and without restenosis following percutaneous transluminal coronary angiography.经皮腔内冠状动脉血管造影术后有再狭窄和无再狭窄患者的纤维蛋白原值。
Cardiology. 1992;80(5-6):345-8. doi: 10.1159/000175024.
8
Lipoprotein(a) in restenosis after percutaneous transluminal coronary angioplasty and coronary artery disease.经皮腔内冠状动脉成形术后再狭窄和冠状动脉疾病中的脂蛋白(a)
Circulation. 1994 Apr;89(4):1593-8. doi: 10.1161/01.cir.89.4.1593.
9
Preventive effects of probucol on restenosis after percutaneous transluminal coronary angioplasty.普罗布考对经皮腔内冠状动脉成形术后再狭窄的预防作用。
Am Heart J. 1996 Jul;132(1 Pt 1):23-9. doi: 10.1016/s0002-8703(96)90386-5.
10
Serum lipids and lipoproteins in relation to restenosis after coronary angioplasty.冠状动脉成形术后再狭窄与血清脂质及脂蛋白的关系。
Eur Heart J. 1991 Sep;12(9):1020-8. doi: 10.1093/eurheartj/12.9.1020.

引用本文的文献

1
Plasmin activation system in restenosis: role in pathogenesis and clinical prediction?再狭窄中的纤溶酶激活系统:在发病机制及临床预测中的作用?
J Thromb Thrombolysis. 1999 Jun;7(3):277-85. doi: 10.1023/a:1008983110941.
2
Genomic instability in the type II TGF-beta1 receptor gene in atherosclerotic and restenotic vascular cells.动脉粥样硬化和再狭窄血管细胞中II型转化生长因子β1受体基因的基因组不稳定性。
J Clin Invest. 1997 Nov 1;100(9):2182-8. doi: 10.1172/JCI119754.